Alexion to buy Portola Pharmaceuticals in $1.41 bln deal
May 05, 2020 at 07:14 AM EDT
Alexion Pharmaceuticals Inc. on Tuesday agreed to buy Portola Pharmaceuticals Inc in a deal that values the U.S. drug developer at $1.41 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.